S189: EARLY, DEEP, AND DURABLE RESPONSES, AND LOW RATES OF CRS WITH REGN5458, A BCMAXCD3 BISPECIFIC ANTIBODY, IN A PHASE 1/2 FIRST-IN-HUMAN STUDY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Authors: J. A. Zonder, J. Richter, N. Bumma, J. Brayer, J. E. Hoffman, W. I. Bensinger, K. L. Wu, L. Xu, D. Chokshi, A. Boyapati, D. Cronier, Y. Houvras, K. Rodriguez Lorenc, G. S. Kroog, M. V. Dhodapkar, S. Lentzsch, D. Cooper, S. Jagannath

Published: 2022-06-23

DOI: 10.1097/01.hs9.0000843648.44771.79

Source: Full article

---

Abstract

No abstract found.